Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Should You Sell Allergan Right Now?
Motley Fool
Wednesday, December 8, 2010 - 12:44pm
tags:
Allergan
Diet Drug Rally: Orexigen, Vivus, Arena
TheStreet.com
Wednesday, December 8, 2010 - 12:27pm
tags:
obesity, Orexigen, Vivus, Arena Pharmaceuticals, Contrave, Qnexa
Can New Leadership Rejuvenate Big Pharma?
Investopedia
Wednesday, December 8, 2010 - 12:25pm
tags:
AstraZeneca, GSK, Eli Lilly, Merck, Novartis, Pfizer, Sanofi
Novo Nordisk Passes This Key Test
Motley Fool
Wednesday, December 8, 2010 - 12:08pm
tags:
Novo Nordisk
Johnson & Johnson Ordered to Pay $700,000 Over Flawed Levaquin Warning
Bloomberg
Wednesday, December 8, 2010 - 12:06pm
tags:
JNJ, Levaquin, settlements, antibiotics
Bullish on Neurocrine Bio After Latest Clinical Trials
Seeking Alpha
Wednesday, December 8, 2010 - 11:59am
tags:
Neurocrine, GnRH antagonists, Abbott Laboratories
Clearing Up the Uncertainty Around MannKind’s Afrezza
Seeking Alpha
Wednesday, December 8, 2010 - 10:01am
tags:
MannKind, inhaled insulin, Afrezza
Sanofi Is Likely to Extend its Takeover Offer for Genzyme, Le Figaro Says
Bloomberg
Wednesday, December 8, 2010 - 10:00am
tags:
Sanofi, M&A, Genzyme
Changing the Perception of the Biotech One-Trick Pony
Seeking Alpha
Wednesday, December 8, 2010 - 9:59am
tags:
Alexion, Dendreon, ImClone, Exelixis, ONYX Pharmaceuticals
Abbott subsidiary Kos reaches $41M settlement
Yahoo/AP
Wednesday, December 8, 2010 - 9:52am
tags:
Abbott Laboratories, Kos, settlements, Advicor, kickbacks
J&J eyes vaccine market with $2.3 billion Crucell bid
Yahoo/AP
Wednesday, December 8, 2010 - 9:50am
tags:
M&A, vaccines, JNJ, Crucell
Show Me the Money, Affymetrix
Motley Fool
Wednesday, December 8, 2010 - 9:49am
tags:
Affymetrix
The Most Promising New Schizophrenia Drug In Years?
Forbes
Tuesday, December 7, 2010 - 7:22pm
tags:
schizophrenia, Roche, RG1678
Drug Pipeline Pulse Check: Spectrum, QRxPharma, CytRx and Impax
Seeking Alpha
Tuesday, December 7, 2010 - 7:21pm
tags:
Spectrum Pharmaceuticals, CytRx, QRxPharma, Impax
How Pfizer's New Chief Can Right the Ship
Motley Fool
Tuesday, December 7, 2010 - 7:18pm
tags:
Pfizer, Ian Read, Jeff Kindler, Pharma CEOs
Orexigen Wins U.S. Panel’s Backing for New Diet Pill
Bloomberg Businessweek
Tuesday, December 7, 2010 - 6:05pm
tags:
obesity, Orexigen, advisory panels, FDA, Contrave
US reaches $421 million settlement with 3 drug companies over allegedly inflated prices
Yahoo/AP
Tuesday, December 7, 2010 - 5:53pm
tags:
DOJ, settlements, Abbott Laboratories, Roxane Laboratories, drug pricing
The Top 10 Pharma Layoffs of 2010
Fierce Pharma
Tuesday, December 7, 2010 - 12:12pm
tags:
layoffs, Pfizer, AstraZeneca, GSK, Roche, Bayer, Abbott Laboratories, Sanofi, Takeda, Novartis, Genzyme
Merck KGaA: Taking a break from big buyouts
Fierce Pharma
Tuesday, December 7, 2010 - 12:09pm
tags:
Merck KGaA, M&A
Onyx jumps on new data for cancer drug carfilzomib
Yahoo/AP
Tuesday, December 7, 2010 - 12:08pm
tags:
ONYX Pharmaceuticals, Carfilzomib

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.